Pfizer Inc
NYSE: PFE
$29.28
-$0.40 (-1.3%)
Closing Price on October 17, 2024
PFE Articles
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive, Pfizer, Valero Energy and...
Published:
Merck finds itself in a position of being an acquirer of sorts at the same time it wants to spin out part of its operations. Executing this effort may create some operational uncertainty inside of...
Published:
Pfizer stock retreated after it released a disappointing fourth-quarter earnings report before the opening bell Tuesday.
Published:
The January 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
As of the most recently reported period, short sellers favored Microsoft, Pfizer and Intel above all other Dow stocks.
Published:
These three health care companies included are expected to report their earnings on Tuesday morning.
Published:
24/7 Wall St. has put together a preview of those Dow Jones industrials scheduled to report their quarterly results this week.
Published:
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
As of the most recently reported period, short sellers favored Microsoft, Intel and Pfizer above all other Dow stocks.
Published:
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
Published:
Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.
Published:
Here is a review and preview of how the model for Dow Jones industrial average could point to a baseline expectation of more than 7% gains in 2020.
Published:
Ahead of election years, the cost and future of health care has become one of the top debates for better than two decades now. Most politicians say that they want to lower prescription drug costs....
Published:
Here, 24/7 Wall St. presents a calendar of a few of the biggest clinical trial and FDA updates to watch for in early 2020.
Published:
Here's a look at the five best- and five worst-performing stocks among the Dow Jones industrial average this past year.
Published: